Product Name: Human TNFRSF5 / CD40 Antibody (Mitazalimab, Research Use)
Catalog Number: NBR-0908
Target Name: TNFRSF5 / CD40
Trade Name: Mitazalimab
Antibody Drug Description: Mitazalimab (ADC-1013, JNJ-64457107) is a human CD40 agonistic antibody developed for immunotherapy of cancer. Activation of CD40, expressed on antigen-presenting cells (APC), leads to improved T cell priming and initiation of T cell-dependent anti-tumor responses. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD40
Synonyms: Bp50; p50; TNFRSF5
Target Description: This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. 
Ensembl: ENSG00000101017
Uniprot: P25942